Close this search box.
Health & WellnessTech


Leaders in Home Stroke Recovery
Investment type:
(Common Stock)
Target raise:
 - $1,069,999
Minimum investment:​
End date:
Oct 27, 2021

Stroke is the #1 cause of long-term disability with a market size that is projected to double between 2010 and 2050. As healthcare costs skyrocket, Saebo’s affordable home-based rehabilitation products improve patient recoveries while lowering the short- and long-term costs of care. A proven track record with 17 patents awarded, a network spanning six continents and over 40 countries, and $44 million in net revenue to date.

Our Story

Saebo’s award-winning rehabilitation products offer stroke survivors a second chance to overcome paralysis and regain quality-of-life. Designed specifically for ease-of-use and affordability, Saebo’s products are targeted to unlock the vast untapped market for in-home neurorehabilitation.
Our Ambition

At Saebo, we believe every patient deserves a helping hand. That means empowering patients with the education, tools, and financial assistance they need to take control of their own recovery.